newsfilter
← Latest News
ACCESS Newswire·

Marijuana Rescheduling Makes Strange Bedfellows: MMJ and State Operators Take Their Battles to Federal Court

  • State-licensed marijuana operators Standard Wellness Utah, Verde Americano, & NW Confections OK 241AA filed petitions on November 18, 2026, to block the DEA's November 29 deadline that restricts trading with non-federal businesses.
  • Four additional Pennsylvania operators filed a separate petition on November 19, 2026, which the D.C. Circuit Court consolidated with the first group under case numbers 26-1324 & 26-1325.
  • The operators admitted under oath that their multimillion-dollar supply chains were built over several years without federal DEA registrations & operate entirely within state lines due to prohibitions on interstate commerce.
  • Standard Wellness Utah spent six years expanding its business while Verde Americano generates roughly $1.15 million in monthly wholesale sales based on relationships developed over four to five years.
  • MMJ International Holdings CEO Duane Boise stated that these filings prove the April 2026 rescheduling order created a state system disguised as a federal one rather than a lawful federal framework.
  • The operators argue that the DEA is unfairly treating businesses differently based solely on the date of their federal filing despite holding identical state licenses.
  • MMJ International Holdings maintains that the April Order was unlawful because it treated state licenses as substitutes for federal review, leaving thousands of state-licensed businesses without established federal origins.
  • The DEA has issued "Show Cause" orders to applicants in California, Delaware, D.C., Illinois, Minnesota, North Dakota, & Oregon citing the Controlled Substances Act's closed system & the 1961 Single Convention on Narcotic Drugs.
  • Article 28 & Article 33 of the 1961 treaty require government-licensed cultivation & total harvest delivery to agencies, which MMJ argues contradicts the existence of state-grown supply chains outside federal control.
  • MMJ BioPharma Cultivation, Inc. has a pending DEA bulk-manufacturer application filed on December 27, 2018, while its subsidiary holds a Schedule I analytical laboratory registration for research into Huntington's disease & multiple sclerosis.
Company
MMJ International Holdings
Keywords
Healthcare & Pharmaceutical, Company Update